Company expects to report topline 12-month clinical results in the second half of 2027BOSTON, June 17, 2026 (GLOBE NEWSWIRE) ...

When we asked three registered dietitians to name the single best frozen fruit to keep in your freezer for smoothies, they ...

The mental health benefits of aerobic exercise are widely known. Runners speak of the runner's high, cardiologists prescribe ...

US Health and Human Services Secretary Robert F. Kennedy Jr. attacks scientific literature with censorship to push MAHA ...

Wearables, AI, supplements, and smart gadgets helped me optimize pregnancy—until they reminded me some things can't be optimized.

Millions of women taking semaglutide or similar GLP-1 receptor agonists for diabetes and obesity now have a new data point to ...

Qure may seek approval in the UK first while in talks with the FDA about its request for a larger, sham-controlled trial of ...

Key findings presented at EAN 2026: In the subset of patients with neurologic symptoms at baseline from the 2:1 randomized Phase 3 FoCus clinical trial (NCT03403205; n=207), ALXN1840 demonstrated ...

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, ...

New obesity drugs are posting surgical-scale weight-loss numbers. Is the gap closing, or are we mistaking early results for the final answer?

If the US FDA approves it, aglatimagene immunotherapy may become the first new therapy for men with localized prostate cancer in the past 2 decades.

A large real-world clinical trial has found that a generative AI-powered support tool used to support frontline clinicians was safe and improved the quality of clinical decision-making, but did not ...